# Amgen Inc. (AMGN) — Q1-2021 Earnings Results

**Report date:** 2021-04-27 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2021

## Post-Earnings Brief

### Headline

Amgen Misses on EPS, Stock Down 0.15%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.70 | N/A | -7.57% |

### Management Commentary

**Tone:** Defensive

Overall, management expressed caution regarding current market conditions. They highlighted the importance of maintaining a steady course amid uncertainties.

**Key quotes:**

> Management acknowledged the challenges faced during the quarter.

> They emphasized a focus on long-term growth despite short-term hurdles.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Amgen's earnings report shows a slight miss on EPS, which may raise concerns among investors about the company's short-term performance. The stock reacted with a minor decline of 0.15%, indicating a muted response from the market. Management's defensive tone suggests they are aware of the challenges ahead but remain focused on long-term strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2021_